As artificial intelligence gains momentum across the pharmaceutical industry, many organizations are discovering that successful implementation depends on more than advanced algorithms alone. Building a strong foundation of high-quality data, standardized processes, and effective governance is essential for transforming AI from a promising concept into a practical tool for development and manufacturing.
From improving data integrity and real-time monitoring to enabling more informed decision-making across operations, AI has the potential to enhance product quality, increase efficiency, and streamline complex manufacturing workflows. Organizations that invest in the right infrastructure today are better positioned to scale AI initiatives and unlock long-term value.
Discover how industry leaders are leveraging AI to drive innovation across drug development and manufacturing in this edition of the Outsourced Pharma Capabilities Update: AI Innovation in Drug Dev. & Mfg. Watch the presentations below to gain actionable insights for building a more data-driven future.
Recent Sessions Available On-Demand
Nanoparticles & Solid Dose Formulation – September 2026
Cell Line Development – August 2026
Large Molecule & Fill/Finish – August 2026
Gene Therapy – August 2026
Upcoming OPCU Topics & Times
Driving Biologics Manufacturing Innovation | 10/27/2026, AM Session
Fill/Finish Excellence | 10/27/2026, PM Session
Advancing Drug Substance Manufacturing | 10/28/2026, AM Session
Small Molecule Drug Product Innovation | 10/28/2026, AM Session
Enabling Success In Cell & Gene Therapy | 10/29/2026, AM Session
Advancing Analytical Capabilities | 10/29/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.
